Long-term Outcomes of Infants with IUDE to Buprenorphine and Methadone
Jo Ann Matory, MD
Primary Investigator
Jessica MacLean
Primary Investigator
Brief description of study
The purpose of this study is to investigate if children born to women who received who were receiving opioid maintenance therapy through one of the following medications: methadone or buprenorphine or buprenorphine/naloxone combination drug during pregnancy will demonstrate increased number of health care provider and medical interventions and lower behavioral assessment scores with delayed motor development when compared with established acceptable normative scorings.
Detailed description of study
The purpose of this study is to investigate if children born to women who received who were receiving opioid maintenance therapy through one of the following medications: methadone or buprenorphine or buprenorphine/naloxone combination drug during pregnancy will demonstrate increased number of health care provider and medical interventions and lower behavioral assessment scores with delayed motor development when compared with established acceptable normative scorings.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions:
-
Age: 100 years or below
-
Gender: All
